original ) (raw )Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
Michael Perdices
Schizophrenia Research and Treatment, 2011
View PDFchevron_right
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro , Francisco Navarrete
Neuropsychopharmacology, 2011
View PDFchevron_right
Biological aspects of cannabis consumption in schizophrenia
dan madalina
Archives of Biological Sciences, 2014
View PDFchevron_right
Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia Efeitos comportamentais, cognitivos e psicofisiológicos de canabinoids: relevância para a psicose e esquizofrenia
Icelini Stavers-Sosa
2010
View PDFchevron_right
Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
Piet de Vries
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014
View PDFchevron_right
Using Knockout Mice Models to Explore Links between THC and Schizophrenia: A Research Protocol
Keerat Grewal
2019
View PDFchevron_right
Therapeutic Potential of Cannabinoids in Schizophrenia
Vincenzo Micale
Recent Patents on CNS Drug Discovery, 2014
View PDFchevron_right
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids
Iain McGregor
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2011
View PDFchevron_right
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
Jan Berle
Frontiers in Psychiatry, 2014
View PDFchevron_right
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes
Lieve Desbonnet
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2011
View PDFchevron_right
Brain cannabinoid CB2 receptor in schizophrenia
Tadao Arinami
2010
View PDFchevron_right
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
Gabriel Braley , Walid Abi-saab
Biological Psychiatry, 2005
View PDFchevron_right
Neurobiology of Comorbid Substance Use Disorders in Mental Illness: A Closer Look at the Underlying Commonalities between Cannabis and Schizophrenia
Rishab Gupta
Current Addiction Reports, 2014
View PDFchevron_right
Cannabis and psychosis: Neurobiology
amresh srivastava
Indian Journal of Psychiatry, 2014
View PDFchevron_right
Cannabis and Psychosis: A Causal Association
Eduardo Leiderman
Psychiatry and Neuroscience Update, 2021
View PDFchevron_right
13.4 Cannabinoid Receptor Gene Polymorphisms and Cognitive Performance in Patients with Schizophrenia
João Salgado
Schizophrenia Bulletin, 2018
View PDFchevron_right
Review Endocannabinoids and Schizophrenia
Stéphane Potvin
2015
View PDFchevron_right
The endocannabinoid system and its role in schizophrenia: a narrative review
IP Innovative Publication Pvt. Ltd.
IP Innovative Publication Pvt. Ltd, 2017
View PDFchevron_right
Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
Sylvain Williams
Molecular Psychiatry, 2012
View PDFchevron_right
Therapeutic Potential of Cannabinoids in Psychosis
Markus Leweke
Biological Psychiatry, 2016
View PDFchevron_right
Cannabis and Schizophrenia
Juan Negrete
Marihuana and Medicine, 1999
View PDFchevron_right
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
Sándor Benyhe
View PDFchevron_right
P.3.f.006 Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviours in mice
Antonio Ortega-Alvaro , Francisco Navarrete
European Neuropsychopharmacology, 2010
View PDFchevron_right
The Endocannabinoid System and its Role in Schizophrenia: A Systematic Review of the Literature
João Salgado
Revista Brasileira de Psiquiatria, 2012
View PDFchevron_right
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
Naielly Rodrigues
Pharmacological Research, 2020
View PDFchevron_right
What is the mechanism whereby cannabis use increases risk of psychosis?
John Powell
Neurotoxicity Research, 2008
View PDFchevron_right
Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
Leonora Long
PLoS ONE, 2012
View PDFchevron_right
Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
Suresh Sundram
Neuroscience, 2001
View PDFchevron_right
Cannabis, cannabinoids and schizophrenia: integration of the evidence
Vaughan Carr
Australian and New Zealand Journal of Psychiatry, 2008
View PDFchevron_right